Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.70NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.70NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.8.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.8.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.8.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EC.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EC.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EC.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XLNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XLNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XLNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.87 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.87 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.87 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.23.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.23.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XNNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XNNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XNNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.111 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.111 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.111 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used